Edwards Lifesciences Files 8-K on Shareholder Votes

TL;DR

EDWARDS LIFESCIENCES FILED AN 8-K ON SHAREHOLDER VOTES FROM MAY 7TH.

AI Summary

Edwards Lifesciences Corporation filed an 8-K on May 8, 2024, reporting on matters submitted to a vote of security holders on May 7, 2024. The filing details the company's corporate actions and governance, as is standard for this type of report.

Why It Matters

This filing provides transparency into the decisions and votes made by Edwards Lifesciences' security holders, which can impact corporate governance and future strategic directions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing reporting on matters submitted to a vote of security holders, with no immediate financial or operational risks indicated.

Key Players & Entities

• Edwards Lifesciences Corporation (company) — Registrant
• May 7, 2024 (date) — Date of earliest event reported
• May 8, 2024 (date) — Date of report

FAQ

Key Financial Figures

• $1.00 — ich registered Common Stock, par value $1.00 per share EW New York Stock Exchange

Filing Documents

• ew-20240507.htm (8-K) — 43KB
• 0001099800-24-000045.txt ( ) — 164KB
• ew-20240507.xsd (EX-101.SCH) — 2KB
• ew-20240507_lab.xml (EX-101.LAB) — 21KB
• ew-20240507_pre.xml (EX-101.PRE) — 12KB
• ew-20240507_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2024, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve until the Company's next annual meeting of stockholders and until their respective successors are duly elected and qualified as set forth below: Nominee For Against Abstain Broker Non-Votes Leslie C. Davis 473,738,064.47 345,701.80 1,585,777.67 30,936,513.00 Kieran T. Gallahue 468,309,861.40 5,841,289.80 1,518,392.74 30,936,513.00 Leslie S. Heisz 465,923,804.47 7,991,526.80 1,754,212.67 30,936,513.00 Paul A. LaViolette 447,816,113.40 25,087,719.80 2,765,710.74 30,936,513.00 Steven R. Loranger 468,748,749.40 5,398,101.80 1,522,692.74 30,936,513.00 Ramona Sequeira 468,877,034.47 5,271,179.80 1,521,329.67 30,936,513.00 Nicholas J. Valeriani 465,402,509.40 8,781,079.80 1,485,954.74 30,936,513.00 Bernard Zovighian 472,046,632.40 2,127,076.80 1,495,834.74 30,936,513.00 Proposal 2 : The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below: For Against Abstain Broker Non-Votes 433,346,235.39 42,323,308.55 0 30,936,513.00 Proposal 3 : Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was approved as set forth below: For Against Abstain Broker Non-Votes 453,240,922.47 53,365,134.47 0 0 Proposal 4 : The approval of the Company's Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below: For Against Abstain Broker Non-Votes 453,798,884.40 21,870,659.54 0 30,936,513.00 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDWARDS LIFESCIENCES CORPORATION By: /s/ Linda J. Park Linda J. Park Date: May 8, 2024 Senior Vice President, Associate General Counsel, and Corporate Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR